Table 3.
The univariate and multivariate regression analysis to identify prognostic factors for increased LV mass index and elevated native T1.
Variable | LV Mass Index | Native T1 | ||||||
---|---|---|---|---|---|---|---|---|
Univariate Analysis | Multivariate Analysis | Univariate Analysis | Multivariate Analysis | |||||
OR (95% CI) | p-Value | OR (95% CI) | p-Value | OR (95% CI) | p-Value | OR (95% CI) | p-Value | |
Male sex |
3.67
(1.39–9.69) |
0.009 | 2.91 (0.89–9.56) |
0.078 | 1.07 (0.33–3.45) |
0.914 | - | - |
Age, yrs | 0.95 (0.90–1.00) |
0.053 | - | - | 0.96 (0.90–1.03) |
0.268 | - | - |
Hs-Tn-I, pg/L | 1.00 (0.99–1.00) |
0.497 | - | - | 1.00 (0.99–1.00) |
0.697 | - | - |
BNP, pg/L |
1.00
(1.00–1.01) |
0.009 | 1.00 (1.00–1.01) |
0.309 | 1.00 (1.00–1.00) |
0.600 | - | - |
LVEF, % |
0.91
(0.86–0.97) |
0.001 | 0.94 (0.87–1.02) |
0.110 |
0.945
(0.90–0.99) |
0.016 | 1.00 (0.92–1.08) |
0.931 |
GLS, % |
0.73
(0.62–0.87) |
<0.001 | - | - |
0.86
(0.75–0.99) |
0.036 | 0.93 (0.74–1.17) |
0.546 |
QRS voltage |
1.09
(1.03–1.15) |
0.002 | 0.98 (0.91–1.06) |
0.679 |
1.10
(1.03–1.18) |
0.006 | 1.08 (0.99–1.18) |
0.093 |
PQ duration, ms | 1.01 (0.99–1.03) |
0.262 | - | - | 1.00 (0.98–1.02) |
0.885 | - | - |
QRS duration, ms | 1.02 (0.99–1.05) |
0.296 | - | - | 1.03 (0.99–1.07) |
0.129 | - | - |
ECG strain |
12.89
(3.90–42.55) |
<0.001 |
7.10
(1.46–34.48) |
0.015 |
4.40
(1.23–15.72) |
0.023 | 1.34 (0.26–7.03) |
0.726 |